2BB score and signals
Maze Therapeutics, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 28 | Low |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2017 |
| Employees | 141 |
| 52-week range | $10.98 – $53.65 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.8027 | — | $0.00 |
| 2026-08-18 | — | -0.7487 | — | $2.04M |
| 2026-05-20 | — | -0.5565 | — | $9.47M |
| 2026-04-06 | — | -0.7201 | — | $0.00 |
2BBBullish & Bearish